POWERFUL MIGRAINE PREVENTION STARTS TODAY
VYEPTI is the first and only intravenous CGRP antagonist (IV anti-CGRP) specifically designed to deliver fast, powerful, and sustained migraine prevention.1-3
Help your patients meet their migraine-free potential today with one 30-minute treatment every 3 months.1
VYEPTI is indicated for the preventive treatment of migraine
in adults.